Literature DB >> 10198245

Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor.

T Yucel-Lindberg1, H Ahola, J Carlstedt-Duke, T Modéer.   

Abstract

The purpose of the present study was to investigate the involvement of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and tyrosine kinase on prostaglandin E2 (PGE2) production in human gingival fibroblasts stimulated by interleukin-1beta (IL-1beta) and/or epidermal growth factor (EGF). The cytokine IL-1beta and to a lesser extent EGF, enhanced COX-2 mRNA levels in gingival fibroblasts. Simultaneous treatment with EGF and IL-1beta resulted in enhanced COX-2 mRNA levels accompanied by a synergistic stimulation of PGE2 biosynthesis compared to the cells treated with IL-1beta or EGF alone. Neither IL-1beta EGF nor the combination of IL-1beta and EGF enhanced COX-1 mRNA levels in gingival fibroblasts. The tyrosine kinase inhibitors, Herbimycin A and PD 153035 hydrochloride, reduced COX-2 mRNA levels as well as PGE2 production induced by IL-1beta or the combination of IL-1beta and EGF whereas COX-1 mRNA levels were not affected. Furthermore, the COX-2 specific inhibitor, NS-398, abolished the PGE2 production induced by IL-1beta, EGF, or the combination. These results indicate that the synergy between IL-1beta and EGF on PGE2 production is due to an enhanced gene expression of COX-2 and that tyrosine kinase(s) are involved in the signal transduction of COX-2 in gingival fibroblasts. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198245     DOI: 10.1006/bbrc.1999.0523

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.

Authors:  D Saha; P K Datta; H Sheng; J D Morrow; M Wada; H L Moses; R D Beauchamp
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  Expression of COX-1 and COX-2 in a clinical model of acute inflammation.

Authors:  Asma A Khan; Michael Iadarola; Hsiu-Ying T Yang; Raymond A Dionne
Journal:  J Pain       Date:  2007-01-30       Impact factor: 5.820

3.  Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.

Authors:  Na Li; Huanhuan Li; Fan Su; Jing Li; Xiaoping Ma; Ping Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.

Authors:  Run-Yue Huang; Shan-Shan Li; Hui-Zhen Guo; Yu Huang; Xian Zhang; Ming-Yue Li; George Gong Chen; Xing Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-03       Impact factor: 4.553

5.  Activation of NFkappaB is necessary for IL-1beta-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts.

Authors:  S Nakao; Y Ogata; E Shimizu-Sasaki; M Yamazaki; S Furuyama; H Sugiya
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

6.  Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma.

Authors:  Huanhuan Li; Yuli Wang; Fan Su; Jing Li; Ping Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture.

Authors:  Hiroaki Takeda; Takeshi Kikuchi; Kyoko Soboku; Iichiro Okabe; Hiroki Mizutani; Akio Mitani; Yuichi Ishihara; Toshihide Noguchi
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

8.  Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study.

Authors:  Likun Chen; Youjian He; He Huang; Hai Liao; Weidong Wei
Journal:  Med Oncol       Date:  2008-01-03       Impact factor: 3.064

Review 9.  Chronic immune activation and inflammation as the cause of malignancy.

Authors:  K J O'Byrne; A G Dalgleish
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

Review 10.  Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis.

Authors:  Jaya Gandhi; Lohit Khera; Nivedita Gaur; Catherine Paul; Rajeev Kaul
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.